you are here: Home News Clsa

Clsa

Nvidia’s earnings surge renews confidence in AI theme, CLSA says fears 'overstated'
CLSA turns 'defensive bullish' on India but warns a flood of IPOs could disrupt market's delicate balance
Bearish sentiment towards India is a good contra-buy signal, says CLSA
BHEL shares fall over 6 percent as CLSA recommends 'Underperform' after net loss doubles
Trump's tariff and penalty undermine India's global safe-haven status, weaken investor interest, says CLSA
CLSA gives 'Outperform' call for Radico Khaitan, 'Hold' for United Spirits
Asian Paints shares sink as CCI orders probe into anti-competitive behavior, CLSA maintains 'underperform'
CLSA sees NHPC shares doubling in four years, helped by projects on fast-track after Indus treaty suspension
CLSA, Morgan Stanley remain cautious on IT, says discretionary spending still weak
Blinkit's weekly user base of over 30 million within striking distance of Zomato; widens lead over Instamart and Zepto: CLSA
US stocks ‘astronomically complacent’ about trade war, says CLSA
CLSA sees 20% upside in MRF shares, sets target price at Rs 1,68,000
Meesho clocks $6.2 billion GMV run rate for FY25; to grow at 26% CAGR through FY31: CLSA
CLSA upgrade fires up Gail's shares on hopes of a potential tariff hike by June
Risk of high reciprocal tariffs on domestic pharma products is low, says CLSA
CLSA maintains 'high-conviction outperform' on NHPC shares, sees 44% upside
CLSA sees Samvardhana Motherson shares doubling within three years, $20 billion revenue by 2029
CLSA sees 50% upside potential in Bandhan Bank shares, maintains 'high conviction outperform'
'Dene wala jab bhi deta...': CLSA is all praises for RBI's recent liquidity relief for lenders
CLSA says Q3 earnings stronger-than-expected, despite consensus doubts
Dollar’s path is key to changing sentiment on emerging market, 30% above fair value: CLSA
CLSA upgrades DLF to 'High Conviction Outperform', sets 28% higher target price
CLSA selects Apollo Hospitals as top pick, says India's pharma set to outpace US growth
Shankar Sharma says CLSA's 'Buy India' note is a 'trap' for retail and DIIs: Here's why
India most insulated among EMs to Trump's tariff plans, China most vulnerable: CLSA's Alexander Redman

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Clsa

Nvidia’s earnings surge renews confidence in AI theme, CLSA says fears 'overstated'

CLSA turns 'defensive bullish' on India but warns a flood of IPOs could disrupt market's delicate balance

Bearish sentiment towards India is a good contra-buy signal, says CLSA

BHEL shares fall over 6 percent as CLSA recommends 'Underperform' after net loss doubles

Trump's tariff and penalty undermine India's global safe-haven status, weaken investor interest, says CLSA

CLSA gives 'Outperform' call for Radico Khaitan, 'Hold' for United Spirits

Asian Paints shares sink as CCI orders probe into anti-competitive behavior, CLSA maintains 'underperform'

CLSA sees NHPC shares doubling in four years, helped by projects on fast-track after Indus treaty suspension

CLSA, Morgan Stanley remain cautious on IT, says discretionary spending still weak

Blinkit's weekly user base of over 30 million within striking distance of Zomato; widens lead over Instamart and Zepto: CLSA

US stocks ‘astronomically complacent’ about trade war, says CLSA

CLSA sees 20% upside in MRF shares, sets target price at Rs 1,68,000

Meesho clocks $6.2 billion GMV run rate for FY25; to grow at 26% CAGR through FY31: CLSA

CLSA upgrade fires up Gail's shares on hopes of a potential tariff hike by June

Risk of high reciprocal tariffs on domestic pharma products is low, says CLSA

CLSA maintains 'high-conviction outperform' on NHPC shares, sees 44% upside

CLSA sees Samvardhana Motherson shares doubling within three years, $20 billion revenue by 2029

CLSA sees 50% upside potential in Bandhan Bank shares, maintains 'high conviction outperform'

'Dene wala jab bhi deta...': CLSA is all praises for RBI's recent liquidity relief for lenders

CLSA says Q3 earnings stronger-than-expected, despite consensus doubts

Dollar’s path is key to changing sentiment on emerging market, 30% above fair value: CLSA

CLSA upgrades DLF to 'High Conviction Outperform', sets 28% higher target price

CLSA selects Apollo Hospitals as top pick, says India's pharma set to outpace US growth

Shankar Sharma says CLSA's 'Buy India' note is a 'trap' for retail and DIIs: Here's why

India most insulated among EMs to Trump's tariff plans, China most vulnerable: CLSA's Alexander Redman